Since most studies demonstrate the anti-cancer activity of compounds by proving the induction of FOXO3 activation through the inhibition of AKT, these results seem to be interesting and unique in that they showed the activation aspect of AKT by eugenol in breast cancer cells. This evidence concerns the gene AKT1 and cancer.